Reported per-share earnings rose 27% to $2.38 at Cardinal Health.
Cardinal Health reported a 27% increase in Q1 FY27 per-share earnings to $2.38, with revenue up 5% to $67.5 billion. Non-GAAP EPS rose 28% to $3.26. The company raised its FY27 non-GAAP EPS guidance to $12.80-$13.00, reflecting 17-19% growth. CEO Jason Hollar attributed the strong performance to strategic investments and operational discipline.
How this was made
The 30-second read
Why it matters
The earnings beat and guidance raise provide short‑term momentum, while the acquisition offers longer‑term growth, creating a layered catalyst for the stock.
Market read
The combined earnings beat, guidance lift, and acquisition news present a multi‑factor catalyst for CAH, likely driving short‑term upside.
What to watch
Potential antitrust review and execution risk of integrating the Diabetes Health business.
Background
Cardinal Health reported Q1 FY2027 results with revenue and earnings growth, raised FY2027 non‑GAAP EPS guidance, completed a $500 M share repurchase, and announced the AdaptHealth acquisition.
Ticker impact
Cardinal Health announced it will complete the acquisition of AdaptHealth's Diabetes Health business in Q3 FY2027 and raised its FY2027 non‑GAAP EPS guidance.
potential upside as investors price in incremental earnings from the Diabetes Health business.
The deal expands Cardinal Health's specialty solutions segment and is coupled with higher guidance, a clear catalyst for share price appreciation.
Market effects
Strengthens the pharmaceutical distribution sector outlook, may boost peers with similar specialty solutions exposure.
U.S. healthcare distribution market sees modest positive sentiment.
Limited to U.S. healthcare investors; no broad macro impact.
Counterpoint
If integration risks materialize or the acquisition price is higher than expected, the stock could face pressure.
Key entities
- CompanyCardinal Health
U.S. pharmaceutical and medical products distributor.
- CompanyAdaptHealth
Provider of diabetes health services being acquired.
